Clinical Trials
8 trialsNCT00042341 2022-05-27
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Sanofi
Phase 2 Completed
NCT02544789 2015-09-09
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
Betta Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT00924443 2015-04-01
A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable
Sanofi
Phase 2 Completed
NCT00042354 2015-03-05
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
Sanofi
Phase 2 Completed
NCT00373529 2014-04-14
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
Sanofi
Phase 2 Completed
NCT00044889 2014-03-19
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Sanofi
Phase 2 Completed
NCT00930098 2014-02-11
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
Sanofi
Phase 2 Completed
NCT01500161 2013-11-25
Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match
Texas Oncology Cancer Center
Phase 2 Terminated